FAKTOR OPTIONSSCHEIN - INCYTE CO. Stock

DE000GG5AY04

Real-time BOERSE MUENCHEN 03:00:19 2024-07-04 EDT
0.504 ^EUR	-18.05%

Current month	-49.47%
1 month	-65.06%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	07-02	MT
S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	07-02	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	07-02	MT
Incyte Shares Fall Following BMO Capital Downgrade	07-02	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-04	0.504	-18.05%
24-07-03	0.615	-25.09%
24-07-02	0.821	-37.57%
24-07-01	1.315	+8.05%
24-06-28	1.217	-24.41%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 03:00 am

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GG5AY0
ISIN	DE000GG5AY04
Date issued	2024-03-15
Strike	55.09 $
Maturity	Unlimited
Parity	4.94 : 1
Emission price	8.45 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	8.39 €
Lowest since issue	0.46 €
Spread	0.02 €
Spread %	4.00%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.66 USD

Average target price

72.62 USD

Spread / Average Target

+25.94%

Consensus